Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lpath Inc (NASDAQ:LPTN)

2.62
Delayed Data
As of 3:59pm ET
 +0.115 / +4.60%
Today’s Change
1.68
Today|||52-Week Range
5.88
-17.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.0M

Company Description

Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA.

Contact Information

Lpath, Inc.
4025 Sorrento Valley Boulevard
San Diego California 92121
P:(858) 678-0800
Investor Relations:

Employees

Shareholders

Other institutional2.42%
Mutual fund holders0.82%
Individual stakeholders--

Top Executives

Gary J. G. AtkinsonCEO, CFO, Secretary & Senior VP
Roger Allen SabbadiniVice President
Leigh HsuVice President-Corporate Development & Strategy